Clinical trial to evaluate two-drug immunotherapy combination in cancer patients with COVID-19
A unique two-drug immunotherapy combination first evaluated at Roswell Park Comprehensive Cancer Center as an approach for treating some cancers will soon be available to cancer patients with COVID-19 through a clinical trial at Roswell Park.
.png)
No hay comentarios:
Publicar un comentario